公司资料
Tactile Systems Technology, Inc. 股价、新闻与催化剂
- 股票代码:
- TCMD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
24.59 USD (+1.61%)
收盘价
最后更新: 2026年8月17日
551M USD
市值
股价为何变动
As of Aug 17, 2026, TCMD closed up 1.61% at $24.59. No new same-company headline was identified in the current news window.
公司概览
At-Home Chronic-Care Therapies
Tactile Medical develops and markets at-home therapies for underserved chronic conditions. Its products help patients manage long-term diseases outside hospitals and clinics while supporting clinician-directed treatment plans.
Lymphedema Portfolio
The company's Flexitouch systems deliver pneumatic compression therapy for lymphedema and related swelling disorders. Its acquisition of LymphaTech broadens the portfolio across the lymphedema-care continuum with measurement and monitoring capabilities.
Airway Clearance
AffloVest is a wearable high-frequency chest-wall oscillation system used by patients with chronic respiratory conditions who need airway-clearance therapy. A next-generation system expands Tactile Medical beyond its core lymphedema franchise.
Compression and Distribution
Tactile Medical also distributes complementary products such as the MyoSleeve wearable compression device. Its commercial model combines direct patient support, clinician engagement, reimbursement services and relationships with government and private payers.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。